INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS
SUICIDALITY AND ANTIDEPRESSANT DRUGS
See full prescribing information for complete boxed warnings.
- TRADE NAMES: Abilify (Bristol-Myers Squibb); Abilitat; Aristada (Alkermes)
- INDICATIONS: Schizophrenia, bipolar I disorder, major depressive disorder, irritability associated with autistic disorder
- CLASS: Antipsychotic, Antipsychotic, atypical, Mood stabilizer
- HALF-LIFE: 75–94 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Alcohol, Atazanavir, Carbamazepine, CYP3A4 inhibitors, Efavirenz, Itraconazole, Ketoconazole, Lopinavir, Nelfinavir, Paroxetine Hydrochloride, Quinidine
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Click on the DRUG REVIEW ARTICLE tab (above) to see a review of aripiprazole in the Informa Healthcare journal Expert Opinion on Drug Safety.
(Note that non-subscribers to the journal will only be able to see an abstract of the article.)
Page last updated 08/22/2024
